Neuehealth, INC Form 4 insider transactions

NeueHealth CFO Jay Matushak exchanged his equity holdings for units in the acquiring entity following the company's merger.

Bessemer Venture Partners and affiliated entities reported the disposition of all direct beneficial ownership in NeueHealth, Inc. common and preferred stock following its acquisition by NH Holdings 2025, Inc.

Stephen Kraus, a director of NeueHealth, Inc., reported the disposition of common and preferred stock following the company's acquisition by NH Holdings 2025, Inc. and a subsequent equity rollover.

NeueHealth GC & Corporate Secretary, Craig Jeffery Michael, exchanged his equity holdings for units in the acquiring entity's parent company following the October 2, 2025 merger.

Tomas Orozco, EVP of Consumer Care at NeueHealth, converted his common stock and restricted stock units into units of the acquiring entity following the company's merger.

NeueHealth Director Robert J. Sheehy reported the disposition of his shares in NeueHealth, Inc. as part of a merger where the company became a wholly-owned subsidiary of NH Holdings 2025, Inc.

NeueHealth Director Kedrick D. Adkins, Jr. exchanged his shares for units in the acquiring private entity following the company's merger.

Manuel Kadre, a director of NeueHealth, Inc., reported the disposition of all his direct and indirect common stock holdings following the company's merger into a subsidiary of NH Holdings 2025, Inc. and a subsequent rollover agreement.

Andrew Slavitt, a director of NeueHealth, Inc., rolled over his equity holdings into the acquiring entity, NH Holdings 2025, Inc., as part of a merger completed on October 2, 2025.

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., reported changes in his beneficial ownership following the company's acquisition by NH Holdings 2025, Inc. on October 2, 2025.

George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported changes in his beneficial ownership following the company's acquisition by NH Holdings 2025, Inc.

Jeffrey R. Immelt, a director of NeueHealth, Inc., reported the disposition of 23,918 common shares following the company's acquisition by NH Holdings 2025, Inc. and a subsequent rollover into the acquiring entity.

NeueHealth Director Linda R Gooden reported the disposition of 16,443 common shares, Series A, and Series B Preferred Stock, which were contributed to NH Holdings 2025 SPV, L.P. in exchange for units as part of a merger effective October 2, 2025.

NeueHealth Director Matthew G. Manders exchanged his shares for units in the acquiring entity following the company's merger into a private subsidiary.

Mohamad Makhzoumi, a Director and 10% owner of NeueHealth, Inc., reported the disposition of all his indirect beneficial ownership in the company's common and preferred stock following a merger on October 2, 2025.

Scott D. Sandell's indirect beneficial ownership in NeueHealth, Inc. changed significantly following the company's merger into a wholly-owned subsidiary on October 2, 2025.

A director and 10% owner of NeueHealth, Inc. reported significant changes in beneficial ownership of common stock, warrants, and preferred stock due to a merger and contribution to a new parent entity.

Paul Edward Walker, a director and 10% owner of NeueHealth, Inc., reported significant changes in his beneficial ownership following the company's merger on October 2, 2025.

Carmen Chang, a director and 10% owner of NeueHealth, Inc., reported significant changes in beneficial ownership following the company's merger into a wholly-owned subsidiary.

Director Ali Behbahani reports the cancellation of NeueHealth, Inc. common and preferred stock following a merger, with holdings converted to private limited partnership interests.

Rick Yang, a director and 10% owner of NeueHealth, reported significant changes in his beneficial ownership due to a merger where shares were exchanged for limited partnership interests.

Edward T. Mathers, a director and 10% owner of NeueHealth, Inc., reported the disposition of all his beneficially owned common stock, warrants, and preferred stock on October 2, 2025, following the company's merger into a wholly-owned subsidiary.

Forest Baskett, a director and 10% owner of NeueHealth, Inc., reported the disposition of all his beneficial holdings in common and preferred stock, and warrants, as part of a merger where NeueHealth became a wholly-owned subsidiary.

NEA 18 Venture Growth Equity, L.P. reported the disposition of all its direct beneficial ownership in NeueHealth, Inc. common and preferred stock following the company's merger into a wholly-owned subsidiary.

New Enterprise Associates 17, L.P. and related entities report the disposition of all NeueHealth, Inc. securities following its acquisition by NH Holdings 2025, Inc.

New Enterprise Associates 16, L.P. reported significant transactions in NeueHealth, Inc. common stock and warrants, culminating in a full disposition of shares due to a merger.

NEA 15 GP, LLC reported a series of transactions related to the merger of NeueHealth, Inc. into a wholly-owned subsidiary, resulting in the contribution and cancellation of its common stock holdings.

New Enterprise Associates 15, L.P. reported the disposition of all its common stock in NeueHealth, Inc. following a merger where the company became a wholly-owned subsidiary.

Director Jeffrey Immelt reports the vesting and disposal of 10,500 restricted stock units in NeueHealth, Inc. on May 13, 2025.

Director Kedrick D. Adkins Jr. of NeueHealth, Inc. reports the vesting and acquisition of 10,500 shares of common stock through restricted stock units on May 13, 2025.